Zobrazeno 1 - 10
of 55
pro vyhledávání: '"Nilda V. Jacobus"'
Autor:
David W. Hecht, Ellie J. C. Goldstein, Duane W. Newton, L. A. McDermott, Lizzie J. Harrell, Stephen G. Jenkins, David R. Snydman, Nilda V. Jacobus, Rakesh Patel
Publikováno v:
Anaerobe. 43:21-26
The susceptibility trends for Bacteroides fragilis and related species against various antibiotics were determined using data from 3 years of surveillance (2010–2012) on 779 isolates referred by 7 medical centers. The antibiotic test panel included
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7a2be441887ef713cef68dd1a5a43981
https://doi.org/10.1016/j.anaerobe.2016.11.003
https://doi.org/10.1016/j.anaerobe.2016.11.003
Autor:
L. A. McDermott, Kathy Kerstein, Joyce A. Sutcliffe, David R. Snydman, Trudy H. Grossman, Nilda V. Jacobus
The novel fluorocycline antibiotic eravacycline is in development for use in the treatment of serious infections caused by susceptible and multidrug-resistant (MDR) aerobic and anaerobic Gram-negative and Gram-positive pathogens. Eravacycline and 11
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::83355f8d1d6d402d47513ac986732403
https://europepmc.org/articles/PMC5923129/
https://europepmc.org/articles/PMC5923129/
Autor:
Cheleste M. Thorpe, Robin Patel, Samuel M. Stone, Nilda V. Jacobus, Stephen G. Jenkins, D. N. Gerding, David R. Snydman, Ellie J. C. Goldstein, Betty A. Forbes, S. Mirrett, S. Johnson, L. A. McDermott
Publikováno v:
Antimicrobial Agents and Chemotherapy. 59:6437-6443
In 2011 a surveillance study for the susceptibility to fidaxomicin and epidemiology of Clostridium difficile isolates in the United States was undertaken in seven geographically dispersed medical centers. This report encompasses baseline surveillance
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fdc531cde7873864e949c68bb97698ba
https://doi.org/10.1128/aac.00845-15
https://doi.org/10.1128/aac.00845-15
Autor:
Darcie E. Roe-Carpenter, Halsey Boyd, Laura M. Koeth, Stephen G. Jenkins, Diane M. Citron, Cynthia C. Knapp, Nilda V. Jacobus, Audrey N. Schuetz, David W. Hecht, Meredith Hackel, Karen Anderson, Maria Karlsson, Christine Hastey, Hannah M. Wexler, Jody Dzink-Fox
Publikováno v:
Anaerobe. 42
Antimicrobial susceptibility testing of anaerobic isolates was conducted at four independent sites from 2010 to 2012 and compared to results from three sites during the period of 2007–2009. This data comparison shows significant changes in antimicr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5f1316099b75441d8756b7a638d7e261
https://pubmed.ncbi.nlm.nih.gov/27427465
https://pubmed.ncbi.nlm.nih.gov/27427465
Autor:
Ellie J. C. Goldstein, Jon E. Rosenblatt, Lizzie J. Harrell, R. Venezia, Sherwood L. Gorbach, Duane W. Newton, Carl L. Pierson, Stephen G. Jenkins, David W. Hecht, L. A. McDermott, Anne Marie Queenan, Nilda V. Jacobus, Yoav Golan, David R. Snydman
Publikováno v:
Anaerobe. 17:147-151
The susceptibility trends for the species of the Bacteroides fragilis group against various antibiotics were determined using data from 4 years [2006–2009] on 1957 isolates referred by 8 medical centers participating in a National Survey for the Su
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::68d90fcb8d04917e7ee809b2d3bc8306
https://doi.org/10.1016/j.anaerobe.2011.05.014
https://doi.org/10.1016/j.anaerobe.2011.05.014
Autor:
Lizzie J. Harrell, Sherwood L. Gorbach, Jack Rihs, Richard A. Venezia, Ellie J. C. Goldstein, Stephen G. Jenkins, David W. Hecht, Nilda V. Jacobus, Paul B. Iannini, David R. Snydman, Laura A. McDermott, Carl L. Pierson, Yoav Golan, Sydney M. Finegold
Publikováno v:
Journal of Antimicrobial Chemotherapy. 52:208-213
Background: Several newer generation fluoroquinolones have demonstrated good in vitro activity against Bacteroides species; particularly when first introduced. However, resistance of Bacteroides to quinolones appears to be increasing. Materials and m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e909f4813a8049cfeb6802e111a89968
https://doi.org/10.1093/jac/dkg320
https://doi.org/10.1093/jac/dkg320
Autor:
Carl L. Pierson, Ellie J. C. Goldstein, Richard A. Venezia, J. Rihs, Stephen G. Jenkins, Lizzie J. Harrell, Robin Ruthazer, Sydney M. Finegold, Nilda V. Jacobus, David W. Hecht, Laura A. McDermott, David R. Snydman, Sherwood L. Gorbach
Publikováno v:
Clinical Infectious Diseases. 35:S126-S134
The results of a multicenter US survey using the National Committee for Clinical Laboratory Standards currently recommended methodology for measuring in vitro susceptibility of 2673 isolates of Bacteroides fragilis group species were compared from 19
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fd3f1f9c5404634ac605ee9eba241e21
https://doi.org/10.1086/341934
https://doi.org/10.1086/341934
Autor:
Sherwood L. Gorbach, J. Rihs, Laura A. McDermott, Stacey Supran, Paul B. Iannini, Carl L. Pierson, G J Cuchural, S. Jenkins, Nilda V. Jacobus, David W. Hecht, David R. Snydman, Sydney M. Finegold, Lizzie J. Harrell
Publikováno v:
Europe PubMed Central
Scopus-Elsevier
Scopus-Elsevier
Antimicrobial resistance, including plasmid-mediated resistance, among the species of the Bacteroides fragilis group is well documented. An analysis of the in vitro susceptibility of B. fragilis group species referred between 1995 and 1996 as well as
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ed0f2ee7a92998a080509ce73c8c57b9
https://doi.org/10.1128/aac.43.10.2417
https://doi.org/10.1128/aac.43.10.2417
Autor:
William J. Weiss, Subas M. Sakya, Nilda V. Jacobus, Francis P. Tally, Karen Bush, Panayota Bitha, Lin Yang I, Stanley A. Lang, Strohmeyer Timothy W, Peter Petersen, Niraja Bhachech, Youjun Yang, Li Zhong, Testa Raymond T, Ving J. Lee
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 7:1671-1676
A series of twelve highly active aminomethyl-THF 1β-methylcarbapenems 3a-1 were synthesized. Of these, carbapenems 3a-f demonstrated a spectrum of antimicrobial activity comparable to those of imipenem and meropenem with the exception of only modera
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7e7cf0fda2095464b1f1974109e04d23
https://doi.org/10.1016/s0960-894x(97)00282-5
https://doi.org/10.1016/s0960-894x(97)00282-5
Publikováno v:
Antimicrobial agents and chemotherapy. 58(2)
We evaluated in vitro activity of ceftolozane-tazobactam (TOL-TAZ), formerly CXA-201, against recent clinical anaerobic isolates with emphasis on the Bacteroides fragilis group. Ceftolozane-tazobactam showed good activity against B. fragilis species
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::473634df911b69f1bd2540f0eb9180be
https://pubmed.ncbi.nlm.nih.gov/24277025
https://pubmed.ncbi.nlm.nih.gov/24277025